Research Article
The Association between Type-2 Diabetes Duration and Major Adverse Cardiac Events after Percutaneous Coronary Intervention
Table 1
Demographic and baseline characteristics.
| | Diabetes duration | for trend# | <5 years | 5 to 10 years | >10 years | |
| Number () | 165 (54.6%) | 72 (23.8%) | 65 (21.5%) | | Gender: male, % | 107 (55.7%) | 42 (21.9%) | 43 (22.4%) | 0.561 | Gender: female, % | 58 (52.7%) | 30 (27.3) | 22 (20%) | Age | | | | 0.141$ | Life style modification % | 164 (99.4%) | 72 (100%) | 65 (100%) | 0.546 | OHA % | 112 (67.9%) | 63 (87.5%) | 56 (86.2%) | 0.001 | Insulin % | 35 (21.2%) | 27 (37.5%) | 33 (50.8%) | 0.001 | OHA and insulin % | 28 (17%) | 22 (30.6%) | 27 (41.5%) | 0.001 | Smoking % | 55 (33.3%) | 19 (26.4%) | 20 (30.8%) | 0.568 | Hypertension % | 111 (67.3%) | 50 (69.4%) | 43 (66.2%) | 0.913 | Heart failure % | 103 (62.4%) | 50 (69.4%) | 46 (70.8%) | 0.372 | Prior MI % | 24 (14.5%) | 14 (19.4%) | 13 (20%) | 0.489 | Prior stroke % | 21 (12.7%) | 14 (19.4%) | 11 (16.9%) | 0.380 | EF % | | | | 0.141$ | BNP Pg/ml | | | | 0.006$ | CK-MB, U/L | | | | 0.351$ | cTnT, ng/L | | | | 0.982$ | HGB, g/L | | | | 0.178$ | Glucose, mmol/L | | | | 0.707$ | HbA1C, % | | | | 0.069$ | Urea, mmol/L | | | | 0.075$ | Creatinine, mmol/L | | | | 0.203$ | eGFR, mL/min/1.73m2 | | | | 0.088$ | T. Cholesterol, mg/dL | | | | 0.444$ | HDL, mmol/L | | | | 0.763$ | LDL, mmol/L | | | | 0.656$ | Triglyceride, mmol/L | | | | 0.153$ | Albumin, g/L | | | | 0.152$ | Medication | | | | | Aspirin + clopidogrel | 110 (67%) | 36 (50%) | 35 (54%) | 0.034 | Aspirin + ticagrelor | 55 (33.3%) | 36 (50%) | 30 (46.1%) | ACE inhibitor | 29 (18%) | 17 (24%) | 13 (20%) | 0.497 | Beta blockers | 123 (75%) | 48 (67%) | 44 (68%) | 0.321 | Statin | 165 (100%) | 72 (100%) | 65 (100%) | 0.000 |
|
|
Data are reported as or (%). OHA: oral hypoglycemic agent; MI: myocardial infarction; EF: ejection fraction; BNP: brain natriuretic peptide; CK-MB: creatinine kinase myocardial band; cTnT: cardiac troponin T; HGB: hemoglobin; HbA1C: glycosylated hemoglobin; eGFR: estimated glomerular filtration rate; T. cholesterol: total cholesterol; HDL: high-density lipoprotein; LDL: low-density lipoprotein; ACE: angiotensin-converting enzyme. #Statistical significances for categorical variables were tested using X2 test for trend. $Statistical significances were tested by one-way ANOVA with trend analysis for continuous variables. |